Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|July 8, 2008
Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1Anita H Lewin, Hernán A Navarro, S Wayne Mascarella
Annals of the New York Academy of Sciences|November 19, 2011
Designer drugs: a medicinal chemistry perspectiveF Ivy Carroll, Anita H Lewin, S Wayne Mascarella, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 6, 2018
Synthesis and Physicochemical Characterization of the One-Carbon Carrier 10-Formyltetrahydrofolate; A Reference Standard for MetabolomicsAnita H Lewin, Peter Silinski, James Hayes, et al.
Life Sciences|October 12, 2013
Emergence and properties of spice and bath salts: a medicinal chemistry perspectiveAnita H Lewin, Herbert H Seltzman, F Ivy Carroll, et al.
Annals of the New York Academy of Sciences|May 13, 2020
Designer drugs: a medicinal chemistry perspective (II)F Ivy Carroll, Anita H Lewin, S Wayne Mascarella, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2012
Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible confounding effects on in vivo and in vitro studiesCharles J McElhinny, Anita H Lewin, S Wayne Mascarella, et al.
The AAPS Journal|January 20, 2007
Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogsBrian F Thomas, Yanan Zhang, Marcus Brackeen, et al.
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
Bupropion and bupropion analogs as treatments for CNS disordersF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
ACS Medicinal Chemistry Letters|December 1, 2010
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor AntagonistsF Ivy Carroll, Juan Pablo Cueva, James B Thomas, et al.
Journal of Medicinal Chemistry|March 3, 2006
N-substituted 4beta-methyl-5-(3-hydroxyphenyl)-7alpha-amidomorphans are potent, selective kappa opioid receptor antagonistsF Ivy Carroll, Matt S Melvin, Michel C Nuckols, et al.
Pageof 5